The mortality rate for pancreas malignant neoplasms in Japan is projected to show a consistent trend from 2024 through 2028, with standardized rates slowly increasing from 17.7 to 17.9 deaths per hundred thousand persons. For context, in 2023, the rate was also around this range, reflecting stability with slight yearly increments. The year-on-year variation from 2024 to 2028 suggests a negligible growth rate, with changes of approximately 0.6% from 2024 to 2028. The Current Average Growth Rate (CAGR) over the entire forecasted period is modest.

Future trends to watch for include:

The impact of advancements in medical technology and early detection on mortality rates.
Potential government healthcare policies aimed at improving cancer treatment outcomes.
Demographic changes affecting the overall aging population in Japan, as older age groups are more susceptible.